Search

Your search keyword '"van Gilst, Wiek H."' showing total 1,247 results

Search Constraints

Start Over You searched for: Author "van Gilst, Wiek H." Remove constraint Author: "van Gilst, Wiek H."
1,247 results on '"van Gilst, Wiek H."'

Search Results

202. Abstract 14059: High Serum Erythropoietin Levels and the Development of Heart Failure in the General Population

203. Abstract 11958: Predicting Heart Failure With Preserved and Reduced Ejection Fraction: The International Collaboration on Heart Failure Subtypes

204. Abstracts of papers clinical pharmacological meeting

205. Genome-wide meta-analysis of common variant differences between men and women

206. Galectin-3, Renal Function, and Clinical Outcomes

207. Cardiac LXR α protects against pathological cardiac hypertrophy and dysfunction by enhancing glucose uptake and utilization

210. Genome-Wide Meta-Analyses of Plasma Renin Activity and Concentration Reveal Association With the Kininogen 1 and Prekallikrein Genes

211. Variants near TERC are associated with mean telomere length

213. Fibrosis Marker Syndecan-1 and Outcome in Patients With Heart Failure With Reduced and Preserved Ejection Fraction

214. The impact of coronary artery disease risk loci on ischemic heart failure severity and prognosis: association analysis in the COntrolled ROsuvastatin multiNAtional trial in heart failure (CORONA)

216. Sex differences in new-onset heart failure

217. Separating the mechanism-based and off-target actions of CETP-inhibitors using CETP gene polymorphisms

218. The gender-specific role of polymorphisms from the fibrinolytic, renin-angiotensin, and bradykinin systems in determining plasma t-PA and PAI-I levels

219. Renal Handling of Galectin‐3 in the General Population, Chronic Heart Failure, and Hemodialysis

221. Clinical Risk Stratification Optimizes Value of Biomarkers to Predict New-Onset Heart Failure in a Community-Based Cohort

222. Effects of Long-Term Averaging of Quantitative Blood Pressure Traits on the Detection of Genetic Associations

224. Genome-Wide Association Study for Circulating Tissue Plasminogen Activator Levels and Functional Follow-Up Implicates Endothelial STXBP5 and STX2

227. HEMOGLOBIN LEVELS AND THE RISK OF NEW ONSET HEART FAILURE IN A COMMUNITY-BASED COHORT: DATA FROM PREVEND

228. Cardiac Function and Architecture Are Maintained in a Model of Cardiorestricted Overexpression of the Prorenin-Renin Receptor

229. Identification of heart rate-associated loci and their effects on cardiac conduction and rhythm disorders

230. Genome-wide association analyses identify 18 new loci associated with serum urate concentrations

231. Genome-wide association analyses identify 18 new loci associated with serum urate concentrations

232. Genome-wide association analyses identify 18 new loci associated with serum urate concentrations

233. B-Type Natriuretic Peptide and Prognosis in Heart Failure Patients With Preserved and Reduced Ejection Fraction

235. Association Between Chromosome 9p21 Variants and the Ankle-Brachial Index Identified by a Meta-Analysis of 21 Genome-Wide Association Studies

236. Vitamin D status and outcomes in heart failure patients

237. Common variants in 22 loci are associated with QRS duration and cardiac ventricular conduction

238. Anaemia is associated with shorter leucocyte telomere length in patients with chronic heart failure.

239. Endogenous erythropoietin and outcome in heart failure.

240. Qualitative examination of compliance in heart failure patients in The Netherlands.

241. Telomere length and outcome in heart failure.

242. Genome-wide association study identifies eight loci associated with blood pressure.

243. Renal dysfunction is associated with shorter telomere length in heart failure.

244. Effect of moderate or intensive disease management program on outcome in patients with heart failure : Coordinating Study Evaluating Outcomes of Advising and Counseling in Heart Failure (COACH).

247. Short-term vitamin D3 supplementation lowers plasma renin activity in patients with stable chronic heart failure: An open-label, blinded end point, randomized prospective trial (VitD-CHF trial)

248. Long Term Effects of Epoetin Alfa in Patients with ST- Elevation Myocardial Infarction

249. A Simple and Computationally Efficient Approach to Multifactor Dimensionality Reduction Analysis of Gene-Gene Interactions for Quantitative Traits

Catalog

Books, media, physical & digital resources